nContact Surgical (Morrisville, North Carolina) said it has received the first investigational device exemption (IDE) from the FDA to evaluate the safety and efficacy of a combined surgical and catheter procedure, which the company has dubbed the convergent procedure, to treat patients with long-standing persistent atrial fibrillation (AF). (Medical Device Daily) Read More
